Find your path to Anne
316 people in our graph share verified history with Anne — schools, employers, funds. One of them is your warm intro.
About
Anne Marije van Harten joined Apollo Health Ventures as an investment director in 2024. Trained as a molecular cell biologist with a focus on targeted therapies in oncology, she previously worked as an investment analyst at Forbion, where she covered biotech companies developing therapeutics for inflammatory, fibrotic, and oncological diseases. She earned BSc and MSc degrees in biomedical sciences and oncology from VU University Amsterdam, completed a PhD at Amsterdam UMC and VU University, and conducted postdoctoral research at the University of Pennsylvania and Thomas Jefferson University.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- Apollo Health VenturesInvestment Directorcurrent2024 — presentLuxembourg
- Apollo Health VenturesDaily Manager Luxembourgcurrent2024 — presentLuxembourg
- Booster TherapeuticsBoard Directorcurrent2025 — presentBerlin, Germany
- Refoxy PharmaBoard Observercurrent2025 — presentCologne, North Rhine-Westphalia, Germany
- Scripta TherapeuticsBoard Observercurrent2025 — presentOxford, England, United Kingdom
- ForbionInvestment Team2022 — 2024Naarden, North Holland, Netherlands
- Thomas Jefferson UniversityPostdoctoral Research Fellow2020 — 2022United States
- Thomas Jefferson UniversityResearch Assistant II2020Philadelphia, Pennsylvania, United States
- University of PennsylvaniaVisiting Scientist at Dept. of Cancer Biology2019Philadelphia, Pennsylvania
- VUmcPhD candidate (promovendus)2013 — 2018Amsterdam Area, Netherlands
Skills & more
+7 more
Strategic PartnershipsDue DiligenceEarly Stage InvestmentPortfolio ManagementInvestor RelationsTranslational ResearchLife SciencesLanguages Dutch · English
From Anne's professional profile.
Colleagues at Apollo Health Ventures
Frequently asked questions
- Who is Anne Marije van Harten?
- Anne Marije van Harten joined Apollo Health Ventures as an investment director in 2024. Trained as a molecular cell biologist with a focus on targeted therapies in oncology, she previously worked as an investment analyst at Forbion, where she covered biotech companies developing therapeutics for inflammatory, fibrotic, and oncological diseases. She earned BSc and MSc degrees in biomedical sciences and oncology from VU University Amsterdam, completed a PhD at Amsterdam UMC and VU University, and conducted postdoctoral research at the University of Pennsylvania and Thomas Jefferson University.
- Where does Anne Marije van Harten work?
- Anne Marije van Harten is Investment Director at Apollo Health Ventures.
- What does Anne Marije van Harten invest in?
- Anne Marije van Harten invests in Biotech.
- Where did Anne Marije van Harten go to school?
- Anne Marije van Harten studied at Vrije Universiteit Amsterdam (VU Amsterdam) (Doctor of Philosophy - PhD (Dr.), Cell/Cellular and Molecular Biology); Vrije Universiteit Amsterdam (VU Amsterdam) (Master of Science (MSc), Oncology); Vrije Universiteit Amsterdam (VU Amsterdam) (Bachelor of Science (BSc), Biomedical Science).
Same school
Also attended Vrije Universiteit Amsterdam (VU Amsterdam)212
+ 206 more
Shared employers
Also worked at Booster Therapeutics4
Also worked at Refoxy Pharma3
Also worked at Scripta Therapeutics5
Also worked at Forbion25
+ 19 more



































